Access to the PPM Journal and newsletters is FREE for clinicians.

Meeting Highlights from European League Against Rheumatism

Meeting Information

June 8-11, 2016

The 16th Annual European Congress of Rheumatology, sponsored by the European League Against Rheumatism (EULAR), was held in London this year. The primary European platform for the exchange of the latest research and topics in rheumatism, the meeting covered a variety of breaking topics in the field of rheumatology. Featured here are some of the most interesting topics presented at the meeting.

From this Meeting:

Rheumatologists are getting closer to having an antibody biomarker that can predict a patient's response to abatacept treatment.
Childhood infections, like appendicits and respiratory tract infections, may be associated with the later development of ankylosing spondylitis—find out why.
Precision treatment: Learn more about genetic tests and the development of blood test for patient with rheumatoid arthritis to improve treatment outcomes.
Researchers highlight on the association between Type 1 diabetes and juvenile idiopathic arthritis and possible genetic underlying factors.
Researchers are developing nanoparticle polymer drug delivery systems that could improve the safety and efficacy of rheumatoid arthritis therapies.
Women with lupus have double the risk of developing cervical cancer. Lear more about the latest research into the possible cause.
close X